Tuesday 25 February |
Sage Group |
Springfield Properties |
Image Scan Holdings |
Wednesday 26 February |
SSP Group |
Van Elle Holdings (re dividend compliance issue) |
Electra Private Equiy |
Bankers Investment Trust |
Aberdeen Diversified Income and Growth Trust |
Jupiter Emerging & Frontier Income Trust |
Polar Capital Global Healthcare Trust |
Thursday 27 February |
Gresham House Energy Storage Fund (re share issue) |
BlackRock Throgmorton Trust |
Legal & General Group (re share settlement structure) |
Friday 28 February |
Green & Smart Holdings |
Merian Chrysalis Investment |
St James House (re share issue) |
Monday 2 March |
MXC Capital (re AIM cancellation) |
Midatech Pharma |
JPMorgan Russian Securities |
Copyright 2020 Alliance News Limited. All Rights Reserved. |
IN BRIEF: Midatech Pharma delisting and name change approved
Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Says resolutions put forward at general meeting, including name change, share consolidation and cancellation of AIM listing, approved. Under the consolidation, every 20 shares will be consolidated into one new ordinary share. Adds that ratio of American depositary shares will change to one ADS per five shares, from one ADS per 25 shares previously. Name change to Biodexa Pharmaceuticals PLC, effective on Monday, also approved. Listing of shares on AIM is expected to be cancelled a month from now. Its sole listing will be on Nasdaq.
Read more